Clinical News

FDA Update

March 2014, Vol 4, No 2 - FDA News

First Drug Combination Approved for Unresectable or Metastatic Melanoma The US Food and Drug Admin­istration (FDA) approved the use of dabrafenib (Tafinlar; GlaxoSmith­Kline) plus trametinib (Mekinist; GlaxoSmithKline) as a new combination therapy for the treatment of patients with advanced melanoma [ Read More ]

New Drug Update

October 2013, Vol 3, No 6 - FDA News

As oncology practice managers assume higher levels of assistance to the medical oncology staff, it becomes critically important to stay abreast of the latest news and updates concerning the drug agents used in cancer treatment. The following drugs have been [ Read More ]